Jove
Visualize
Contact Us

Related Experiment Videos

Metronidazole.

B E Scully1

  • 1Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York.

The Medical Clinics of North America
|May 1, 1988
PubMed
Summary
This summary is machine-generated.

Metronidazole effectively treats anaerobic infections and parasitic diseases by targeting specific pathways. This review details its pharmacokinetics, toxicities, and optimal usage guidelines for clinicians.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Periumbilical parasitic thumbprint purpura: strongyloides hyperinfection syndrome acquired from a cadaveric renal transplant.

Transplant infectious disease : an official journal of the Transplantation Society·2010
Same author

Infections during left ventricular assist device support do not affect posttransplant outcomes.

Circulation·2000
Same author

The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·1997
Same author

Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1993
Same author

Mupirocin treatment of nasal staphylococcal colonization.

Archives of internal medicine·1992
Same author

Home intravenous antibiotic therapy.

New Jersey medicine : the journal of the Medical Society of New Jersey·1992
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Metronidazole is a crucial antimicrobial agent.
  • It exhibits efficacy against anaerobic bacteria and protozoa.
  • Understanding its properties is vital for clinical application.

Purpose of the Study:

  • To provide a comprehensive review of metronidazole.
  • To detail its pharmacokinetic profile and toxicities.
  • To suggest appropriate indications and dosages.

Main Methods:

  • Literature review of existing studies on metronidazole.
  • Analysis of pharmacokinetic data.
  • Compilation of toxicity information and clinical guidelines.

Main Results:

Related Experiment Videos

  • Metronidazole demonstrates potent activity against a spectrum of anaerobic pathogens.
  • Key pharmacokinetic parameters influencing efficacy and safety were identified.
  • Common and rare toxicities associated with metronidazole therapy were documented.

Conclusions:

  • Metronidazole remains a cornerstone therapy for anaerobic and protozoal infections.
  • Adherence to recommended dosages and awareness of potential toxicities are essential.
  • Further research may refine its application in specific clinical scenarios.